Galena Biopharma (GALE) – StreetInsider.com Reports
-
Galena Biopharma (GALE) Shareholders Approve SELLAS Merger, Sets Reverse Stock Split Ratio
-
Galena Biopharma (GALE) Reports Completion of Enrollment in Two NeuVax (nelipepimut-S) Clinical Trials in Combination with Trastuzumab
-
Galena Biopharma (GALE) Says Nasdaq Notified it of Additional 180-day Grace Period to Regain Compliance with Minimum Bid Price Requirement
-
Galena Biopharma (GALE) to Merge with SELLAS Life Sciences Group
-
Galena Biopharma (GALE) Reports Update on GALE-401 & NeuVax (nelipepimut-S)
-
Russell Announces 3000 Index Preliminary Additions and Deletions
-
SEC targets fake stock news on financial websites
-
Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)
-
Galena Biopharma (GALE) Presents Positive Interim Safety Data on NeuVax Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at AACR
-
Pre-Open Movers 03/17: (GALE) (TIF) (ADBE) Higher; (ESPR) (MDCO) (AMGN) Lower (more...)
-
Galena Biopharma (GALE) Soars 25% Pre-Market on Positive GALE-301 Clinical Data
-
Galena Biopharma (GALE) Announces Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data
-
Galena Biopharma (GALE) Reports Q4 Loss of $0.17/Share
-
Galena Biopharma (GALE) Engages Canaccord Genuity to Advise on Previoulsy Announced Review of Strategic Alternatives
-
Galena Biopharma (GALE) Names Stephen Ghiglieri as Interim CEO
-
Las Vegas Sands CEO says Japan casino resort could cost up to $10 billion
-
Pre-Open Stock Movers 02/08: (MYGN) (COHR) (MCHP) Higher; (GALE) (USNA) (EYES) Lower (more...)
-
Galena Biopharma (GALE) Prices Offering at $1/Share, w/Warrants
-
Galena Biopharma (GALE) to Offer Common Stock and Warrants
-
Galena Biopharma (GALE) Pares Gains After Opening Sharply Higher
-
Pre-Open Movers 02/06: (GALE) (HAS) (COG) Higher; (TIF) (IP) (BLUE) Lower (more...)
-
Galena Biopharma (GALE) Reports Positive Outcome from DSMB on Two NeuVa Trials in Combination with Trastuzumab
-
FBR Capital Downgrades Galena Biopharma (GALE) to Market Perform
-
Maxim Group Downgrades Galena Biopharma (GALE) to Hold
-
Galena Biopharma (GALE) to Evaluation of Strategic Alternatives; CEO Resigns
-
Galena Biopharma (GALE) Halted, News Pending
-
Galena Biopharma (GALE) Says It's Being Investigated in Criminal and Civil Probe Related to Abstral Promotional Practices
-
Galena Biopharma (GALE): FDA Pathway Lowers the Last Hurdle for GALE-401 - FBR
-
Maxim Group Reiterates Bullish View on Galena Biopharma (GALE) as GALE-401 is Going Pivotal in 2017
-
Unusual 11 Mid-Day Movers 12/29: (KOOL) (FBIO) (MBLY) Higher; (CEMP) (IDXG) (LIVE) Lower (more...)
-
Galena Biopharma (GALE) Adds to Early Gains After Confirming Regulatory Pathway to Advance GALE-401
-
Pre-Open Stock Movers 12/28: (LIVE) (GALE) (OCRX) Higher; (ANTH) (QCOM) Lower (more...)
-
Galena Biopharma (GALE) Gains 29% in Pre-Open Trader After Confirming Regulatory Pathway to Advance GALE-401
-
Galena Biopharma (GALE) Regulatory Pathway for GALE-401 Confirmed
-
Galena Biopharma (GALE), Former CEO Reach Agreement in Principle with SEC
-
Galena Biopharma (GALE) Phase 2 Clinical Trial of NeuVax Open for Enrollment and Screening Patients
-
Galena Biopharma (GALE) Presents Two Posters at SABCS
-
Streetinsider.com's Hot Lunchtime Reads 12/2: (FNMA) (SRPT) (GALE) (NVCN)
-
Galena Biopharma (GALE) PT Raised to $4 at Maxim Group into San Antonio Breast Cancer Symposium
-
Unusual 11 Mid-Day Movers 11/21: (CHNR) (GALE) (HW) Higher; (GLBS) (SGNL) (TSN) Lower
-
Galena Biopharma (GALE) Shares Ramp to Session Highs
-
Unusual 11 Mid-Day Movers 11/14: (CRBP) (DRYS) (HAR) Higher; (DVAX) (RSO) (HEAR) Lower
-
Galena Biopharma (GALE) Reports Q3 Loss of $0.02/Share
-
Galena Biopharma (GALE) Names New CFO
-
Galena Biopharma (GALE) Plans 1-for-20 Reverse Stock Split
-
Galena Biopharma (GALE) Announces Presentation of GALE-301, GALE-302 Data at ASC Clinical Congress 2016
-
Galena Biopharma (GALE) Files 2M Share Common Stock Shelf for Shareholders
-
Galena Biopharma (GALE) Announces Presentation of NeuVax Combo 2b Interim Safety Data
-
Galena Biopharma (GALE) Files 14M Share Common Stock Shelf for Selling Shareholders
-
Galena Biopharma (GALE) Plans Presentation of Interim NeuVax Combo Phase 2b Data at ESMO 2016
Back to GALE Stock Lookup